Publications by authors named "Charles D Blanke"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

204

Total Likes

281

Extended Reach

626,148

Social Features

147
A
Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer.
Christopher Mackintosh, Chen Yuan, Fang-Shu Ou, Sui Zhang, Donna Niedzwiecki, I-Wen Chang, Bert H O'Neil, Brian C Mullen, Heinz-Josef Lenz, Charles D Blanke

November 2020

Videos about Article: user user

2 5 145 10 88 2

View All Article and Social Media Activity
O
Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: A combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance).
Francesca Battaglin, Bert H O'Neil, Sebastian Stintzing, Fang-Shu Ou, Tyler J Zemla, Charles D Blanke

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort.
Young Kwang Chae, Megan Othus, Sandip Pravin Patel, Raid Aljumaily, Khine Z Win, Charles D Blanke

Cancer Commun (Lond)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plant-based diet and survival among patients with metastatic colorectal cancer.
En Cheng, Fang-Shu Ou, Clare Gatten, Chao Ma, Alan P Venook, Charles D Blanke

J Natl Cancer Inst· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar Cancers.
Young Kwang Chae, Lucy Corthell, Sandip Pravin Patel, Robert Edwards, Jennifer M Scalici, Charles D Blanke

Clin Cancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma.
Sandip P Patel, Eleanor Cano-Linson, Young Kwang Chae, Shiruyeh Schokrpur, Christopher D Lao, Charles D Blanke

NPJ Precis Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer.
Young Kwang Chae, Megan Othus, Sandip Pravin Patel, Kelly J Wilkinson, Emily M Whitman-Purves, Charles D Blanke

Clin Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience: invasive mucinous or non-mucinous lepidic adenocarcinoma of the lung (formerly bronchioloalveolar carcinoma).
Young Kwang Chae, Megan Othus, Sandip Pravin Patel, David E Gerber, Tawee Tanvetyanon, Charles D Blanke

Ther Adv Med Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer.
Sandip P Patel, Elizabeth Guadarrama, Young Kwang Chae, Michael J Dennis, Benjamin C Powers, Charles D Blanke

Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant imatinib in high-risk resected gastrointestinal stromal tumors: Merely delaying the inevitable?
Thomas L Sutton, Kevin G Billingsley, Alicia J Johnson, Christopher L Corless, Charles D Blanke

J Surg Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405.
Francesca Battaglin, Fang-Shu Ou, Xueping Qu, Howard S Hochster, Donna Niedzwiecki, Charles D Blanke

J Clin Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pragmaticism in Cancer Clinical Trials.
Kamya Sankar, Mary W Redman, Konstantin H Dragnev, Brian S Henick, Wade T Iams, Charles D Blanke

Am Soc Clin Oncol Educ Book· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA Mutational Profiling in Patients With Colorectal Cancer Treated With Standard of Care Reveals Differences in Outcome and Racial Distribution of Mutations.
Federico Innocenti, Wancen Mu, Xueping Qu, Fang-Shu Ou, Omar Kabbarah, Charles David Blanke

J Clin Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safeguards for medical aid in dying.
Charles D Blanke

Br J Hosp Med (Lond)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Approach to Accelerate Lung Cancer Research: Lung-MAP and the Potential of Public-Private Partnerships.
Roy S Herbst, Charles D Blanke, Ellen V Sigal

Clin Cancer Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The New NCI Precision Medicine Trials.
Lyndsay N Harris, Charles D Blanke, Harry P Erba, James M Ford, Robert J Gray

Clin Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance).
Justin C Brown, Chao Ma, Qian Shi, Tyler Zemla, Felix Couture, Charles D Blanke

Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To the Editor.
Charles D Blanke

Am J Bioeth· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor.
Michael C Heinrich, Christopher L Corless, George D Demetri, Charles D Blanke, Margaret von Mehren

J Clin Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crisis of the Clinical Trials Staff Attrition After the COVID-19 Pandemic.
Grace Sun, Don S Dizon, Connie M Szczepanek, Daniel P Petrylak, Dana B Sparks, Charles David Blanke

JCO Oncol Pract· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies.
Joseph M Unger, Michael LeBlanc, Suzanne George, Norman Wolmark, Walter J Curran, Charles D Blanke

J Clin Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
Sepideh Gholami, Sarah Colby, David P Horowitz, Katherine A Guthrie, Edgar Ben-Josef, Charles D Blanke

Ann Surg Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary fat in relation to all-cause mortality and cancer progression and death among people with metastatic colorectal cancer: Data from CALGB 80405 (Alliance)/SWOG 80405.
Erin L Van Blarigan, Chao Ma, Fang-Shu Ou, Tiffany M Bainter, Alan P Venook, Charles D Blanke

Int J Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials.
Joseph M Unger, Riha Vaidya, Kathy S Albain, Michael LeBlanc, Lori M Minasian, Charles D Blanke

J Clin Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab.
Federico Innocenti, Akram Yazdani, Naim Rashid, Xueping Qu, Fang-Shu Ou, Charles David Blanke

Clin Cancer Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis